In Vitro Cellular & Developmental Biology Animal · Nov 6, 2026

Nuclear receptor NR4A1 enhances the osteogenic differentiation of BMSCs and improves TCP scaffold-mediated bone repair in mice

By Hu H, Huo X, Deng R et al.

Functional reconstruction of calvarial defect is a considerable clinical challenge. Many studies have emphasized the osteogenic abilities of stem cells for tissue regeneration. Ttricalcium phosphate (TCP) has been employed successfully as a synthetic graft material in bone defect repair. However, the lack of osteogenic and osteoinductive properties of this substitute invariably results in bone regeneration of low quality and quantity. The purpose of this study was to determine whether loading NR4A1 gene-modified bone marrow mesenchymal stem cells (BMSCs) onto TCP promoted bone regeneration and osteointegration of calvarial defect in mice. Alizarin red staining and qPCR were performed to investigate the influences of NR4A1 on osteogenic differentiation of BMSCs and MC3T3-E1 cells. The effects of NR4A1 overexpressed BMSCs/TCP scaffold on osteogenic differentiation of BMSCs were assessed using Alizarin red staining, ALP staining and qPCR. To further evaluate the roles of NR4A1 overexpressed BMSCs/TCP scaffold in osteogenesis in vivo, we conducted animal experiments in mice. New bone formation was assessed using micro-CT and histological methods. In the present study, we found that NR4A1 promotes osteogenic differentiation of BMSCs and MC3T3-E1 cells in vitro. Besides, NR4A1 overexpressed BMSCs/TCP scaffold showed stronger osteogenic differentiation ability than TCP scaffold in vitro. Finally, In vivo studies have shown that micro-CT and histology revealed significantly greater volume of new bone formation in the NR4A1 overexpressed BMSCs/TCP scaffold group than in the model group. HE staining of lung, liver, kindey and heart tissues showed that the TCP scaffold was not toxic to mice. These results demonstrated that combinations of TCP scaffolds and NR4A1 gene-modified BMSCs could be used to construct tissue-engineered bone to enhance mineralization of the regenerated bone and osseointegration in mice.

doi.org/10.1007/s11626-026-01258-9PubMed 42995333Interventions

AgingResearch.News